The Journal of Haemophilia Practice
Launched in 2014, The Journal of Haemophilia Practice is an international, open-access, peer-reviewed journal that aims to provide a forum for all members of the multidisciplinary bleeding disorders care team.
It is now widely recognised that the care and management of people with haemophilia and other rare bleeding disorders should always be based on a multidisciplinary approach, with value placed on the specific expertise brought by allied health care professionals, including nurses, physiotherapists, data managers, social workers, and psychologists. We believe that sharing experience on evidence-based care helps to promote expertise and benefits patients.
The Journal of Haemophilia Practice accepts original research, case reports, case series, methodology papers, clinical updates, reviews, and opinion pieces, as well as outcomes research written by and/or with individuals affected by bleeding disorders.
“Many nurses and allied health professionals now study beyond degree level and are undertaking qualitative research as part of masters and doctoral level study. Supporting publication of their work enhances the care that is provided to people with bleeding disorders through shared patient experience and outcome.”
Kate Khair, Editor in Chief, The Journal of Haemophilia Practice
Alongside experts in bleeding disorders care from around the world, our editorial board includes several members of the international bleeding disorders community who work in academia and patient advocacy.
Tami Barazani-Brutman, Sheba Medical Center at Sheba, Tel Hashomer Hospital, Israel
Paul Batty, Queen Mary University of London, UK, and Queen’s University, Ontario, Canada
Greig Blamey, Health Sciences Center, University of Alberta, Canada
Erica Crilly, British Columbia Children’s Hospital, Vancouver, Canada
Janine Furmedge, The Royal Children’s Hospital Haemophilia Centre, Melbourne, Australia
Rich Gorman, Brighton and Sussex Medical School, UK
Chris Guelcher, Children’s National Hospital, Washington, USA
Chris Harrington, Royal Free Hospital, London, UK
Cathy Harrison, Sheffield Haemophilia & Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK
Dan Hart, The Royal London Hospital and Barts Health NHS Trust, London, UK
Adam Jones, University of Sunderland, UK
Radek Kaczmarek, Indiana University School of Medicine, USA
Sebastien Lobet, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Paul McLaughlin, Royal Free Hospital, London, UK
Greta Mulders, Erasmus University Medical Center, Rotterdam, The Netherlands
James Munn, University of Michigan Hemophilia and Coagulation Disorders Program, Michigan, USA
Declan Noone, European Haemophilia Association, Brussels
Jamie O’Hara, University of Chester, Cheshire, UK
Debra Pollard, Royal Free Hospital, London, UK
BJ Ramsay, Wellington Haemophilia Centre, Wellington, New Zealand
Dakota J. Rosenfelt, PharmD, Missouri, USA
Sylvia von Mackensen, Institute of Medical Psychology at the University Medical Centre, Hamburg, Germany
Linda Myrin Westesson, Sahlgrenska University Hospital, Gothenburg, Sweden
Michelle Witkop, National Hemophilia Foundation, USA
Publication of the journal is possible thanks to the support we receive from our partners in the pharmaceutical industry, who provide support on an annual or three-yearly basis, with a corporate donation. This support has allowed us to continue to publish and to promote the journal within the community without needing to secure advertising or turn to a purely “pay-for-publication” strategy.
This journal is currently sponsored by: